NeVa Clear Study: The Results

We are excited to share the extremely positive results of the NeVa CLEAR* study from our partner Vesalio:

“The prospective study confirms the value and differentiation of the NeVa device compared to other stent retrievers for achieving rapid and effective revascularization,” stated Prof. Dr. Serdar Geyik, who presented the results at the ESMINT meeting in Marseille, France, on behalf of the principal investigators of CLEAR.

We are proud of this achievement. Here is the full press release: read the press release →

*The CLEAR study, a prospective, multicenter IDE trial regulated by the FDA, highlighted the safety and efficacy of Vesalio’s NeVa thrombectomy device in treating acute ischemic stroke caused by large vessel occlusions (LVO).